Preparation of Hot-Melt-Extruded Solid Dispersion Based on Pre-Formulation Strategies and Its Enhanced Therapeutic Efficacy

In this study, an amorphous solid dispersion containing the poorly water-soluble drug, bisacodyl, was prepared by hot-melt extrusion to enhance its therapeutic efficacy. First, the miscibility and interaction between the drug and polymer were investigated as pre-formulation strategies using various...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Seon-Kwang Lee (Autor), Eun-Sol Ha (Autor), Heejun Park (Autor), Kyu-Tae Kang (Autor), Ji-Su Jeong (Autor), Jeong-Soo Kim (Autor), In-hwan Baek (Autor), Min-Soo Kim (Autor)
Formato: Livro
Publicado em: MDPI AG, 2023-11-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b43364c40a8e453d9a89c6247158fc7c
042 |a dc 
100 1 0 |a Seon-Kwang Lee  |e author 
700 1 0 |a Eun-Sol Ha  |e author 
700 1 0 |a Heejun Park  |e author 
700 1 0 |a Kyu-Tae Kang  |e author 
700 1 0 |a Ji-Su Jeong  |e author 
700 1 0 |a Jeong-Soo Kim  |e author 
700 1 0 |a In-hwan Baek  |e author 
700 1 0 |a Min-Soo Kim  |e author 
245 0 0 |a Preparation of Hot-Melt-Extruded Solid Dispersion Based on Pre-Formulation Strategies and Its Enhanced Therapeutic Efficacy 
260 |b MDPI AG,   |c 2023-11-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15122704 
500 |a 1999-4923 
520 |a In this study, an amorphous solid dispersion containing the poorly water-soluble drug, bisacodyl, was prepared by hot-melt extrusion to enhance its therapeutic efficacy. First, the miscibility and interaction between the drug and polymer were investigated as pre-formulation strategies using various analytical approaches to obtain information for selecting a suitable polymer. Based on the calculation of the Hansen solubility parameter and the identification of the single glass transition temperature (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><msub><mi>T</mi><mi>g</mi></msub></mrow></semantics></math></inline-formula>), the miscibility between bisacodyl and all the investigated polymers was confirmed. Additionally, the drug-polymer molecular interaction was identified based on the comprehensive results of dynamic vapor sorption (DVS), Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy, and a comparison of the predicted and experimental values of <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><msub><mi>T</mi><mi>g</mi></msub></mrow></semantics></math></inline-formula>. In particular, the hydroxypropyl methylcellulose (HPMC)-based solid dispersions, which exhibited large deviation between the calculated and experimental values of <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><msub><mi>T</mi><mi>g</mi></msub></mrow></semantics></math></inline-formula> and superior physical stability after DVS experiments, were selected as the most appropriate solubilized bisacodyl formulations due to the excellent inhibitory effects on precipitation based on the results of the non-sink dissolution test. Furthermore, it was shown that the enteric-coated tablets containing HPMC-bisacodyl at a 1:4 ratio (<i>w</i>/<i>w</i>) had significantly improved in vivo therapeutic laxative efficacy compared to preparations containing un-solubilized raw bisacodyl in constipation-induced rabbits. Therefore, it was concluded that the pre-formulation strategy, using several analyses and approaches, was successfully applied in this study to investigate the miscibility and interaction of drug-polymer systems, hence resulting in the manufacture of favorable solid dispersions with favorable in vitro and in vivo performances using hot-melt extrusion processes. 
546 |a EN 
690 |a hot-melt extrusion 
690 |a solid dispersion 
690 |a miscibility 
690 |a molecular interaction 
690 |a bisacodyl 
690 |a in vivo efficacy 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 12, p 2704 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/12/2704 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/b43364c40a8e453d9a89c6247158fc7c  |z Connect to this object online.